Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil versus metoprolol for prevention of progression of paroxysmal atrial fibrillation
NL-OMON44431Not yet recruiting
- Sponsor
- Martini Ziekenhuis
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib) comparing Verapamil slow release with Metoprolol slow release (2 arms). Primary endpoint: Incidence of atrial fibrillation progression or need for pulmonary vein isolation. Planned start Aug 2017; status: not yet recruiting.
02
Drugs
verapamilmetoprolol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NL-OMON44431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44431.